Harmony Biosciences Holdings, Inc. - Common Stock — Cash Flow (NASDAQ:HRMY) | MetaTrader

Open full chart

Financials

Overview Statement Statistics Documents

Quarterly Annual

Cash from operating activities -2.98 M98.56 M144.47 M219.39 M219.82 M348.2 M 355.08 M Cash from investing activities -2 M-100.3 M-141.83 M-46.44 M-67.48 M-39.65 M -337.57 M Cash from financing activities 209.16 M7.42 M6.84 M-105.55 M-11 M-9.05 M -13.79 M Free cash flow -2.98 M98.56 M144.47 M219.39 M219.82 M347.89 M 354.9 M

News

AI Memory Leader Everpure Among 16 Joining Best Stock Screens

This Atlassian Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday - ACM

Making Drugs With AI: Biopharma Giants Gear Up For New Arena

BridgeBio Q2 Earnings Miss, Revenues Beat as Attruby Sales Surge

ANIP Tops Q2 Earnings, Stock Down on Cortrophin Sales View Cut

OTLK Up More Than 300% in 3 Months: Here's What You Should Know

Here's Why Replimune Stock Skyrockets Nearly 223% in 3 Months

Immunocore's Q2 Earnings Miss Estimates, Kimmtrak Aids Y/Y Revenues

Ocugen's Q2 Earnings Miss Estimates as R&D Costs Rise, Stock Falls

BMRN Stock Up as Q2 Earnings Beat on Sales Growth, 2026 Outlook Raised

PBYI Q2 Earnings & Sales Beat Estimates, 2026 Guidance Raised

NTLA Q2 Earnings In Line, Top Line Misses on Lower Regeneron Revenues